Additional sample collection centres have been launched as part of the Emirati Genome Programme’s expansion in the emirate of Abu Dhabi.
The programme aims to sequence the complete genome of as many UAE citizens as possible to support the prediction, prevention and treatment of genetic and chronic illnesses.
The data will be used to develop healthcare strategies to address the population’s specific needs.
Sample collection sites now include the Abu Dhabi National Exhibition Centre (ADNEC), Biogenix Labs in Masdar City, Al Towayya in Al Ain, Al Ain Convention Centre, and CurePlus Medical Centre, Al Ain.
Emiratis can also visit Burjeel Hospital’s network of medical facilities in Abu Dhabi, as well as NMC Healthcare’s network in the emirate.
All UAE nationals are invited to take part in the programme by visiting one of the sample collection sites and providing a single blood sample.
A team will be available at the sites to guide participants through the process.
The programme operates in line with the highest ethical and governance standards and ensures the anonymity of all participants and the date of their blood donation.


H.H. Sheikh Mohamed highlights UAE-Germany ties at Bundestag
Dubai unveils school framework to coach students for jobs of the future
UAE and German Presidents discuss strengthening bilateral ties
UAE President accorded official reception at Berlin's Villa Borsig
UAE team rescues 6 missing in flood-hit Nepal
UAE President begins state visit to Germany
UAE, seven others back UK action on illegal Israeli settlements
Sheikh Nahyan bin Mubarak represents UAE at funeral of Norway's King
